ARTL
Artelo Biosciences Inc
NASDAQ: ARTL · HEALTHCARE · BIOTECHNOLOGY
$3.49
+2.35% today
Updated 2026-04-30
Market cap
$3.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-37.56
Dividend yield
—
52W range
$3 – $86
Volume
4.2M
Artelo Biosciences Inc (ARTL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |